|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Grant revenue | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest income | |||||
| Interest expense | |||||
| Miscellaneous income | |||||
| Foreign currency exchange, net | |||||
| Total other income (expense), net | |||||
| Loss before income taxes | |||||
| Income tax benefit | |||||
| Net loss | |||||
| Basic net loss per share | |||||
| Diluted net loss per share | |||||
| Weight average shares outstanding, basic | |||||
| Weight average shares outstanding, diluted | |||||
Loading...